Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas.
Patel
S R
SR
Department of Sarcoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. spatel@mdanderson.org
Jenkins
J
J
Papadopolous
N
N
Burgess
M A
MA
Plager
C
C
Gutterman
J
J
Benjamin
R S
RS
D000328:Adult; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C112567:etaracizumab